Nuvalent, Inc. (NUVL)
96.43
+1.66
(+1.75%)
USD |
NASDAQ |
Mar 23, 16:00
96.38
-0.05
(-0.05%)
After-Hours: 20:00
Nuvalent Total Liabilities (Quarterly) : 164.37M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Glaukos Corp. | 274.22M |
| Edgewise Therapeutics, Inc. | 30.35M |
| Cogent Biosciences, Inc. | 301.24M |
| Neurocrine Biosciences, Inc. | 1.500B |
| BioMarin Pharmaceutical, Inc. | 1.507B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.413B |
| Shareholders Equity (Quarterly) | 1.248B |
| Current Ratio | 15.27 |